| Net Cash Provided by (Used in) Operating Activities |
11.3M |
USD |
+33.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
368M |
USD |
+87.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-385M |
USD |
-83.2% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
3.5B |
shares |
+16.7% |
Q3 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
0 |
shares |
|
Q1 2023 |
Q1 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-5.79M |
USD |
-4.08% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
147M |
USD |
+341% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
31.8M |
USD |
+221% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
50.6M |
USD |
+212% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
815M |
USD |
+119% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
36.1M |
USD |
+772% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |